Vitamin E Dosing Study

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 5, 2022

Primary Completion Date

March 4, 2025

Study Completion Date

June 30, 2025

Conditions
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Interventions
DRUG

Vitamin E

Participants will be assigned to take 200 IU, 400 IU, or 800 IU of vitamin E in matching capsules daily for 24 weeks

DRUG

Placebo

Participants will take a placebo vitamin E capsule daily for 24 weeks

Trial Locations (9)

23298

Virginia Commonwealth University, Richmond

27710

Duke University Medical Center, Durham

44195

Cleveland Clinic Foundation, Cleveland

46202

Indiana University- Adults, Indianapolis

63110

St. Louis University, St Louis

90089

University of Southern California, Los Angeles

92103

University of California, San Diego, La Jolla

94143

University of California, San Francisco, San Francisco

98105

Liver Institute Northwest, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Liver Institute Northwest

UNKNOWN

collaborator

Indiana University

OTHER

collaborator

St. Louis University

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

University of Southern California

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

Virginia Commonwealth University

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH